Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Mawdsleys are proud to support International Health Partners, who have recently collaborated with Radio 4 in an appeal to raise much needed funds for their vital work.   The appeal was based on maternal health, and aimed to raise funds for essential medicines required during pregnancy and childbirth, to ensure…